Related Experiment Video

Updated: Aug 15, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Physicians' early challenges related to the pneumococcal conjugate vaccine

M M Davis1, M Andreae, G L Freed

  • 1Division of General Pediatrics, Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor 48109-0456, USA. mattdav@med.umich.edu

Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association
|March 13, 2002
PubMed

Insights

Physicians faced parental resistance and insurance issues when recommending the 7-valent pneumococcal conjugate vaccine (Prevnar). Cost concerns and caution also delayed adoption of this important childhood vaccine.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • National recommendations introduced the 7-valent pneumococcal conjugate vaccine (Prevnar) for young children.
  • Physician adoption of new vaccines can be influenced by various implementation challenges.

Purpose of the Study:

  • To identify obstacles encountered by physicians in administering the pneumococcal vaccine.
  • To understand early decision-making processes for childhood vaccine implementation.

Main Methods:

  • Conducted semistructured telephone interviews with 24 pediatricians and family physicians.
  • Sample included physicians who were and were not recommending the pneumococcal vaccine.

Main Results:

  • Eighteen physicians recommended the vaccine; six did not.
  • Recommending physicians faced parental resistance and inconsistent insurance coverage.
  • Non-recommending physicians cited cost concerns and caution regarding new recommendations.

Conclusions:

  • Physician decision-making highlights potential barriers to childhood vaccine implementation.
  • Understanding these obstacles is crucial for future vaccine rollouts.
Abstract

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...